PARACETAMOL ZENTIVA LAB 500 mg, scored tablet 16 tablets
Active ingredients: Paracetamol
Commercialized according to BDPM
Scored tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PARACETAMOL ZENTIVA LAB 500 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 16 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Jun 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61411557CIP73024859CIP133400930248591Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.